 Juan Idrovo
Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 3 | 2021 | 180 | 2.230 |
Why?
| | Liver Diseases | 2 | 2021 | 270 | 1.550 |
Why?
| | Reperfusion Injury | 3 | 2015 | 288 | 1.330 |
Why?
| | 4-Butyrolactone | 2 | 2015 | 21 | 1.160 |
Why?
| | Aminoimidazole Carboxamide | 2 | 2015 | 12 | 1.140 |
Why?
| | Wound Healing | 2 | 2016 | 294 | 1.060 |
Why?
| | Inflammation | 3 | 2020 | 2171 | 1.020 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 3 | 0.920 |
Why?
| | Severe Acute Respiratory Syndrome | 1 | 2020 | 15 | 0.900 |
Why?
| | Alcoholic Intoxication | 1 | 2019 | 63 | 0.820 |
Why?
| | Coronavirus Infections | 2 | 2020 | 357 | 0.710 |
Why?
| | Betacoronavirus | 2 | 2020 | 273 | 0.710 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 374 | 0.710 |
Why?
| | Hepatic Insufficiency | 1 | 2015 | 3 | 0.650 |
Why?
| | Adrenomedullin | 1 | 2015 | 3 | 0.640 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2012 | 46 | 0.630 |
Why?
| | Ribonucleotides | 1 | 2015 | 28 | 0.620 |
Why?
| | Lipogenesis | 1 | 2015 | 77 | 0.610 |
Why?
| | Pandemics | 2 | 2020 | 585 | 0.610 |
Why?
| | Complement Factor H | 1 | 2015 | 61 | 0.600 |
Why?
| | Liver | 2 | 2020 | 1802 | 0.570 |
Why?
| | Shock, Hemorrhagic | 1 | 2016 | 207 | 0.550 |
Why?
| | Skin | 2 | 2016 | 662 | 0.550 |
Why?
| | RNA-Binding Proteins | 1 | 2016 | 335 | 0.520 |
Why?
| | Ribonucleosides | 1 | 2012 | 8 | 0.510 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2011 | 38 | 0.500 |
Why?
| | Intestines | 1 | 2015 | 302 | 0.500 |
Why?
| | Renal Circulation | 1 | 2011 | 65 | 0.500 |
Why?
| | Renal Artery | 1 | 2011 | 32 | 0.490 |
Why?
| | Carnitine | 1 | 2012 | 63 | 0.490 |
Why?
| | Arterial Occlusive Diseases | 1 | 2011 | 82 | 0.470 |
Why?
| | Acute Lung Injury | 1 | 2015 | 313 | 0.470 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 448 | 0.470 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 944 | 0.460 |
Why?
| | Sepsis | 1 | 2015 | 418 | 0.440 |
Why?
| | Energy Metabolism | 2 | 2012 | 905 | 0.390 |
Why?
| | Aspartate Aminotransferases | 2 | 2021 | 103 | 0.380 |
Why?
| | Recovery of Function | 1 | 2012 | 571 | 0.380 |
Why?
| | Kidney | 2 | 2012 | 1121 | 0.380 |
Why?
| | Alanine Transaminase | 2 | 2021 | 150 | 0.370 |
Why?
| | Kidney Transplantation | 1 | 2011 | 432 | 0.370 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2020 | 1194 | 0.340 |
Why?
| | Rats, Sprague-Dawley | 4 | 2015 | 3223 | 0.340 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 568 | 0.330 |
Why?
| | Animals | 9 | 2021 | 34264 | 0.330 |
Why?
| | Cough | 3 | 2020 | 92 | 0.320 |
Why?
| | Fever | 3 | 2020 | 297 | 0.300 |
Why?
| | Mice | 5 | 2021 | 14765 | 0.290 |
Why?
| | Interleukin-6 | 2 | 2020 | 674 | 0.290 |
Why?
| | Neovascularization, Physiologic | 2 | 2016 | 180 | 0.280 |
Why?
| | Peroxidase | 2 | 2015 | 207 | 0.270 |
Why?
| | Rats | 4 | 2015 | 6717 | 0.270 |
Why?
| | Travel | 2 | 2020 | 132 | 0.260 |
Why?
| | Dyspnea | 2 | 2020 | 168 | 0.250 |
Why?
| | Malondialdehyde | 1 | 2021 | 32 | 0.240 |
Why?
| | Chemokine CXCL1 | 1 | 2020 | 79 | 0.230 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 167 | 0.230 |
Why?
| | Blood Cell Count | 1 | 2020 | 60 | 0.230 |
Why?
| | Gastric Inhibitory Polypeptide | 1 | 2019 | 9 | 0.220 |
Why?
| | Resistin | 1 | 2019 | 13 | 0.220 |
Why?
| | China | 1 | 2020 | 207 | 0.220 |
Why?
| | Ghrelin | 1 | 2019 | 33 | 0.220 |
Why?
| | Adenosine Triphosphate | 2 | 2012 | 461 | 0.210 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2019 | 83 | 0.210 |
Why?
| | Glutathione | 1 | 2021 | 371 | 0.210 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2019 | 91 | 0.200 |
Why?
| | Disease Models, Animal | 2 | 2021 | 3738 | 0.190 |
Why?
| | Leptin | 1 | 2019 | 224 | 0.190 |
Why?
| | Respiratory Tract Infections | 1 | 2020 | 258 | 0.190 |
Why?
| | Interleukin-1beta | 1 | 2020 | 391 | 0.190 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1265 | 0.180 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 4997 | 0.180 |
Why?
| | Models, Animal | 1 | 2019 | 392 | 0.180 |
Why?
| | Influenza, Human | 1 | 2020 | 448 | 0.160 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2015 | 124 | 0.150 |
Why?
| | Bacterial Load | 1 | 2015 | 65 | 0.150 |
Why?
| | Male | 7 | 2020 | 58392 | 0.150 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 106 | 0.150 |
Why?
| | Hospitalization | 2 | 2020 | 1486 | 0.150 |
Why?
| | Lung | 2 | 2020 | 3434 | 0.150 |
Why?
| | Ethanol | 1 | 2019 | 688 | 0.150 |
Why?
| | Age Factors | 1 | 2021 | 3221 | 0.130 |
Why?
| | Spasm | 1 | 2011 | 13 | 0.130 |
Why?
| | Female | 4 | 2021 | 59707 | 0.120 |
Why?
| | Lymph Nodes | 1 | 2015 | 460 | 0.120 |
Why?
| | Edema | 1 | 2012 | 112 | 0.120 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 152 | 0.120 |
Why?
| | Gallbladder Neoplasms | 1 | 2011 | 10 | 0.120 |
Why?
| | Leukocytes | 1 | 2012 | 269 | 0.110 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2011 | 81 | 0.110 |
Why?
| | Blood Glucose | 1 | 2019 | 1689 | 0.110 |
Why?
| | Blood Flow Velocity | 1 | 2011 | 345 | 0.110 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 498 | 0.110 |
Why?
| | Living Donors | 1 | 2011 | 188 | 0.110 |
Why?
| | Insulin | 1 | 2019 | 1972 | 0.110 |
Why?
| | Treatment Outcome | 2 | 2015 | 8608 | 0.110 |
Why?
| | Neutrophils | 1 | 2015 | 1156 | 0.100 |
Why?
| | Fatty Acids | 1 | 2012 | 374 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 995 | 0.100 |
Why?
| | Risk Factors | 1 | 2020 | 8467 | 0.090 |
Why?
| | Signal Transduction | 1 | 2020 | 4845 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1913 | 0.080 |
Why?
| | Biomarkers | 1 | 2015 | 3163 | 0.080 |
Why?
| | Humans | 6 | 2020 | 104249 | 0.070 |
Why?
| | Infectious Disease Incubation Period | 1 | 2020 | 4 | 0.060 |
Why?
| | Pharyngitis | 1 | 2020 | 25 | 0.060 |
Why?
| | Influenza B virus | 1 | 2020 | 33 | 0.060 |
Why?
| | Influenza A virus | 1 | 2020 | 105 | 0.050 |
Why?
| | Time Factors | 1 | 2011 | 7066 | 0.050 |
Why?
| | Survival Analysis | 1 | 2020 | 1406 | 0.040 |
Why?
| | Electronic Health Records | 1 | 2020 | 589 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2653 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2264 | 0.030 |
Why?
| | Adult | 1 | 2011 | 30359 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2011 | 6518 | 0.010 |
Why?
| | Aged | 1 | 2011 | 18934 | 0.010 |
Why?
|
|
Idrovo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|